Corporate Profile

Simulations Plus, Inc. (NASDAQ GSM: SLP) is the leading developer of modeling and simulation software for the pharmaceutical and biotechnology industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better project decisions… sooner.

Latest Quarterly Results

2nd Quarter Fiscal Year 2022 Results Press Release

2nd Quarter Fiscal Year 2022 Earnings Release Presentation

2nd Quarter Fiscal Year 2022 Webcast Info

Latest Investor Presentation

 


 

Upcoming Investor Presentations

Craig Hallum 19th Annual Institutional Investor Conference

Date: 6/1/22